Approval · Notice of Compliance 2638 · 2001
TARKA: Notice of Compliance 2638
Issued June 22, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2638
- Date
- June 22, 2001
- Company
- Abbott Laboratories Co.Saint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Change in manufacturer's name
- Therapeutic class
- Antihypertensive agent
Products in this notice
Medicinal ingredients
- VERAPAMIL HCL 240 MG per TAB
- TRANDOLAPRIL 4 MG per TAB
- TRANDOLAPRIL 2 MG per TAB
- TRANDOLAPRIL 1 MG per TAB
- VERAPAMIL HCL 180 MG per TAB